TY - JOUR AU - Kia, Arash AU - Waterson, James AU - Bargary, Norma AU - Rolt, Stuart AU - Burke, Kevin AU - Robertson, Jeremy AU - Garcia, Samuel AU - Benavoli, Alessio AU - Bergström, David PY - 2023 DA - 2023/9/13 TI - Determinants of Intravenous Infusion Longevity and Infusion Failure via a Nonlinear Model Analysis of Smart Pump Event Logs: Retrospective Study JO - JMIR AI SP - e48628 VL - 2 KW - intravenous infusion KW - vascular access device KW - alarm fatigue KW - intensive care units KW - intensive care KW - neonatal KW - predictive model KW - smart pump KW - smart device KW - health device KW - infusion KW - intravenous KW - nonlinear model KW - medical device KW - therapy KW - prediction model KW - artificial intelligence KW - AI KW - machine learning KW - predict KW - predictive KW - prediction KW - log data KW - event log AB - Background: Infusion failure may have severe consequences for patients receiving critical, short–half-life infusions. Continued interruptions to infusions can lead to subtherapeutic therapy. Objective: This study aims to identify and rank determinants of the longevity of continuous infusions administered through syringe drivers, using nonlinear predictive models. Additionally, this study aims to evaluate key factors influencing infusion longevity and develop and test a model for predicting the likelihood of achieving successful infusion longevity. Methods: Data were extracted from the event logs of smart pumps containing information on care profiles, medication types and concentrations, occlusion alarm settings, and the final infusion cessation cause. These data were then used to fit 5 nonlinear models and evaluate the best explanatory model. Results: Random forest was the best-fit predictor, with an F1-score of 80.42, compared to 5 other models (mean F1-score 75.06; range 67.48-79.63). When applied to infusion data in an individual syringe driver data set, the predictor model found that the final medication concentration and medication type were of less significance to infusion longevity compared to the rate and care unit. For low-rate infusions, rates ranging from 2 to 2.8 mL/hr performed best for achieving a balance between infusion longevity and fluid load per infusion, with an occlusion versus no-occlusion ratio of 0.553. Rates between 0.8 and 1.2 mL/hr exhibited the poorest performance with a ratio of 1.604. Higher rates, up to 4 mL/hr, performed better in terms of occlusion versus no-occlusion ratios. Conclusions: This study provides clinicians with insights into the specific types of infusion that warrant more intense observation or proactive management of intravenous access; additionally, it can offer valuable information regarding the average duration of uninterrupted infusions that can be expected in these care areas. Optimizing rate settings to improve infusion longevity for continuous infusions, achieved through compounding to create customized concentrations for individual patients, may be possible in light of the study’s outcomes. The study also highlights the potential of machine learning nonlinear models in predicting outcomes and life spans of specific therapies delivered via medical devices. SN - 2817-1705 UR - https://ai.jmir.org/2023/1/e48628 UR - https://doi.org/10.2196/48628 DO - 10.2196/48628 ID - info:doi/10.2196/48628 ER -